Servier Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
200 Pier 4 Blvd, Boston, Massachusetts, ...Phone Number
(888) 788-1735Website
www.servier.usRevenue
$148.9 MillionIndustry
About Servier Pharmaceuticals
Servier Pharmaceuticals is a leader in oncology and is expanding its neurology business, focusing on addressing rare diseases and patient populations with unmet needs. The company is committed to delivering meaningful therapeutics through a robust research and development pipeline and partnerships. With 50 active programs in oncology and neurology, Servier aims to provide new therapeutic options for smaller patient populations. Their dedication to science and patient care drives their mission to improve the lives of those they serve.Explore more
Servier Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Servier Pharmaceuticals
Compare insights from companies similar to Servier Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$50.7M
51-200
Private
-
1999
AO
Aram OganesianVice President, Clinical Pharmacology & Nonclinical Development
Servier Pharmaceuticals Tech Stack
A closer look at the technologies used by Servier Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Servier Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Servier Pharmaceuticals is a leader in oncology and is expanding its neurology business, focusing on addressing rare diseases and patient populations with unmet needs. The company is committed to delivering meaningful therapeutics through a robust research and development pipeline and partnerships. With 50 active programs in oncology and neurology,... Read More
